Hormones and genes of importance in bone physiology and their influence on bone mineralization and growth in Turner syndrome.
This mini review summarizes papers presented in a Joint Symposium between the Bone, Growth Plate and Turner Syndrome Working Groups of the European Society for Paediatric Endocrinology (ESPE) that was held on September 9, 2009, in New York.The program had been composed to give an update on hormones and genes of importance in bone physiology and their influence on bone mineralization and growth in Turner syndrome. This paper summarizes the data and highlights the main topics and discussions related to each presentation.
Andrade
Anenisia C
AC
Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. anenisia.andrade@ki.se
Baron
Jeffrey
J
Manolagas
Stavros C
SC
Shaw
Nick J
NJ
Rappold
Gudrun A
GA
Donaldson
Malcolm D C
MD
Gault
Emma Jane
EJ
Sävendahl
Lars
L
D000293:Adolescent; D001827:Body Height / Q000187:drug effects; D015519:Bone Density; D001846:Bone Development / Q000187:drug effects; D001851:Bone Diseases, Metabolic / Q000209:etiology; D002113:Calcification, Physiologic / Q000187:drug effects; D002356:Cartilage / Q000187:drug effects / Q000254:growth & development; D002648:Child; D005260:Female; D018398:Homeodomain Proteins / Q000235:genetics / Q000502:physiology; D006801:Humans; D010074:Oxandrolone / Q000627:therapeutic use; D018384:Oxidative Stress / Q000502:physiology; D000074122:Short Stature Homeobox Protein; D014424:Turner Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D018398:Homeodomain Proteins; C106071:SHOX protein, human; D000074122:Short Stature Homeobox Protein; D010074:Oxandrolone